CKPT — Checkpoint Therapeutics Share News
0.000.00%
Last trade - 00:00- $370.71m
- $337.66m
- $0.04m
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say
U.S. STOCKS ON THE MOVE-Veren, CME Group, Cognizant
U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, Redfin
U.S. STOCKS ON THE MOVE-Airbnb, Beacon, Redfin
Checkpoint Therapeutics rises on $355 million Sun Pharma buyout deal
Deals of the day-Mergers and acquisitions
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million (updated)
India's Sun Pharma to acquire Checkpoint Therapeutics
U.S. STOCKS ON THE MOVE-HeartBeam, Teradyne, Keysight Technologies
U.S. STOCKS ON THE MOVE-Novo Nordisk, Tesla, MicroStrategy
U.S. STOCKS ON THE MOVE-NetApp, Honeywell, CBRE Group
Checkpoint Therapeutics rises after FDA approval of co's skin cancer drug
US FDA approves Checkpoint's skin cancer drug (updated)
Brief: Checkpoint Therapeutics Announces FDA Approval Of Unloxcyt (Cosibelimab-Ipdl)